Abstract
Phenotypic high content screening (HCS) has resurged in recent years as an important platform in the drug discovery paradigm, particularly to address the serious challenges in the current target based approaches. Using the highly conserved heat shock response (HSR) pathway as a therapeutic intervention point, we established a cell based, high throughput, multiplexing, and disease relevant phenotypic screening platform for small molecule HSF1 modulators in cancer and neurodegenerative diseases. In this chapter, the authors reviewed their systematic design of methodology and workflow in detail, including the characterization of cellular phenotypic changes, image analysis and quantification, assay development and automation, screening operation and quality control, counter-screen and lead optimization, target identification and mechanism of action study. Selected compounds from the phenotypic screening, including novel HSF1 activators and HSF1 inhibitors, were discussed in regard to their chemical structures, therapeutic effects, and cytotoxicity for potential drug development. The authors also addressed the uncertainties and risks in target deconvolution, which still remains to be the most difficult hurdle in phenotypic screening. Recent HCS advances in tissues, organs and whole organisms, such as 3D tissue imaging, organ-on-a chip, IPS derived cell models, relevant animal models, etc., may bring an effective solution for delivering target-specific, first-in-class drugs in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alastalo TP, Hellesuo M, Sandqvist A, Hietakangas V, Kallio M, Sistonen L (2003) Formation of nuclear stress granules involves HSF2 and coincides with the nucleolar localization of Hsp70. J Cell Sci 116(Pt 17):3557–3570
Anckar J, Sistonen L (2011) Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu Rev Biochem 80:1089–1115
Au Q, Kanchanastit P, Barber JR, Ng SC, Zhang B (2008) High-content image-based screening for small-molecule chaperone amplifiers in heat shock. J Biomol Screen 13(10):953–959
Au Q, Zhang Y, Barber JR, Ng SC, Zhang B (2009) Identification of inhibitors of HSF1 functional activity by high-content target-based screening. J Biomol Screen 14(10):1165–1175
Avior Y, Sagi I, Benvenisty N (2016) Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 17(3):170–182
Bhatia SN, Ingber DE (2014) Microfluidic organs-on-chips. Nat Biotechnol 32(8):760–772
Bilgin CC, Fontenay G, Cheng Q, Chang H, Han J, Parvin B (2016) BioSig3D: high content screening of three-dimensional cell culture models. PLoS One 11(3):e0148379
Boutros M, Heigwer F, Laufer C (2015) Microscopy-based high-content screening. Cell 163(6):1314–1325
Calderwood SK, Murshid A (2017) Molecular chaperone accumulation in cancer and decrease in Alzheimer's disease: the potential roles of HSF1. Front Neurosci 11:192
Cheeseman MD, Chessum NE, Rye CS, Pasqua AE, Tucker MJ, Wilding B, Evans LE, Lepri S, Richards M, Sharp SY, Ali S, Rowlands M, O'Fee L, Miah A, Hayes A, Henley AT, Powers M, Te Poele R, De Billy E, Pellegrino L, Raynaud F, Burke R, van Montfort RL, Eccles SA, Workman P, Jones K (2017) Discovery of a chemical probe Bisamide (CCT251236): an orally bioavailable efficacious Pirin ligand from a heat shock transcription factor 1 (HSF1) phenotypic screen. J Med Chem 60(1):180–201
Cher C, Tremblay MH, Barber JR, Ng SC, Zhang B (2010) Identification of chaulmoogric acid as a small molecule activator of protein phosphatase 5. Appl Biochem Biotechnol 160(5):1450–1459
Chessel A (2017) An overview of data science uses in bioimage informatics. Methods 115:110–118
Cotto J, Fox S, Morimoto R (1997) HSF1 granules: a novel stress-induced nuclear compartment of human cells. J Cell Sci 110(Pt 23):2925–2934
Dai C, Whitesell L, Rogers AB, Lindquist S (2007) Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130(6):1005–1018
Daugaard M, Rohde M, Jäättelä M (2007) The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett 581(19):3702–3710
Dayalan NS, Dinkova-Kostova AT (2017) Regulation of the mammalian heat shock factor 1. FEBS J 284(11):1606–1627
De Thonel A, Mezger V, Garrido C (2011) Implication of heat shock factors in tumorigenesis: therapeutical potential. Cancers (Basel) 3(1):1158–1181
Denegri M, Moralli D, Rocchi M, Biggiogera M, Raimondi E, Cobianchi F, De Carli L, Riva S, Biamonti G (2002) Human chromosomes 9, 12, and 15 contain the nucleation sites of stress- induced nuclear bodies. Mol Biol Cell 13(6):2069–2079
Donato MT, Gómez-Lechón MJ, Tolosa L (2017) Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies. Expert Opin Drug Discovery 12(2):201–211
Eder J, Sedrani R, Wiesmann C (2014) The discovery of first-in-class drugs: origins and evolution. Nat Rev Drug Discov 13:577–587
Fellmann C, Gowen BG, Lin PC, Doudna JA, Corn JE (2017) Cornerstones of CRISPR-Cas in drug discovery and therapy. Nat Rev Drug Discov 16:89–100
Fetz V, Prochnow H, Bronstrup M, Sasse F (2016) Target identification by image analysis. Nat Prod Rep 33:655–667
Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O’Boyle DR 2nd, Lemm JA, Wang C, Knipe JO, Chien C, Colonno RJ, Grasela DM, Meanwell NA, Hamann LG (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465(7294):96–100
Gomez-Pastor R, Burchfiel ET, Thiele DJ (2017) Regulation of heat shock transcription factors and their roles in physiology and disease. Nat Rev Mol Cell Biol Aug 30. https://doi.org/10.1038/nrm.2017.73 [Epub ahead of print]
Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253–295
Harvey AL, Edrada-Ebel R, Quinn RJ (2015) The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 14:111–129
Horvath P, Aulner N, Bickle M, Davies AM, Nery ED, Ebner D, Montoya MC, Östling P, Pietiäinen V, Price LS, Shorte SL, Turcatti G, von Schantz C, Carragher NO (2016) Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov 15(11):751–769
Jolly C, Usson Y, Morimoto RI (1999) Rapid and reversible relocalization of heat shock factor 1 within seconds to nuclear stress granules. Proc Natl Acad Sci U S A 96(12):6769–6774
Jolly C, Konecny L, Grady DL, Kutskova YA, Cotto JJ, Morimoto RI, Vourc'h C (2002) In vivo binding of active heat shock transcription factor 1 to human chromosome 9 heterochromatin during stress. J Cell Biol 156(5):775–781
Jolly C, Metz A, Govin J, Vigneron M, Turner BM, Khochbin S, Vourc'h C (2004) Stress-induced transcription of satellite III repeats. J Cell Biol 164(1):25–33
Jones LH, Bunnage ME (2017) Applications of chemogenomic library screening in drug discovery. Nat Rev Drug Discov 16:285–296
Khurana V, Tardiff DF, Chung CY, Lindquist S (2015) Toward stem cell-based phenotypic screens for neurodegenerative diseases. Nat Rev Neurol 11(6):339–350
Li L, Zhou Q, Voss TC, Quick KL, LaBarbera DV (2016) High-throughput imaging: Focusing in on drug discovery in 3D. Methods 96:97–102
Lindquist SL, Kelly JW (2011) Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis. Cold Spring Harb Perspect Biol 3(12):a004507
Liu C, Su J, Yang F, Wei K, Ma J, Zhou X (2015) Compound signature detection on LINCS L1000 big data. Mol BioSyst 11(3):714–722
Mattiazzi UM, Styles EB, Verster AJ, Friesen H, Boone C, Andrews BJ (2016) High-content screening for quantitative cell biology. Trends Cell Biol 26(8):598–611
Moffat JG, Rudolph J, Bailey D (2014) Phenotypic screening in cancer drug discovery - past, present and future. Nat Rev Drug Discov 13:588–602
Moffat JG, Vincent F, Lee JA, Eder J, Prunotto M (2017) Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat Rev Drug Discov 16(8):531–543
Moore JD (2015) The impact of CRISPR–Cas9 on target identification and validation. (2015). Drug Discov Today 20:450–457
Moutsatsos IK, Parker CN (2016) Recent advances in quantitative high throughput and high content data analysis. Expert Opin Drug Discovery 11(4):415–423
Neef DW, Jaeger AM, Thiele DJ (2011) Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat Rev Drug Discov 10(12):930–944
Neudegger T, Verghese J, Hayer-Hartl M, Hartl FU, Bracher A (2016) Structure of human heat-.shock transcription factor 1 in complex with DNA. Nat Struct Mol Biol 23(2):140–146
Nijman SM (2015) Functional genomics to uncover drug mechanism of action. Nat Chem Biol 11:942–948
Nyström A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L (2015) Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol Med 7(9):1211–1228
Pegoraro G, Misteli T (2017) High-throughput imaging for the discovery of cellular mechanisms of disease. Trends Genet 33(9):604–615
Persson M, Hornberg JJ (2016) Advances in predictive toxicology for discovery safety through high content screening. Chem Res Toxicol 29(12):1998–2007
Petersen DN, Hawkins J, Ruangsiriluk W, Stevens KA, Maguire BA, O’Connell TN, Rocke BN, Boehm M, Ruggeri RB, Rolph T, Hepworth D, Loria PM, Carpino PA (2016) A small-molecule anti-secretagogue of PCSK9 targets the 80S ribosome to inhibit PCSK9 protein translation. Cell Chem Biol 23(11):1362–1371
Phukan J (2010) Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis. IDrugs 13(7):482–496
Rye CS, Chessum NE, Lamont S, Pike KG, Faulder P, Demeritt J, Kemmitt P, Tucker J, Zani L, Cheeseman MD, Isaac R, Goodwin L, Boros J, Raynaud F, Hayes A, Henley AT, de Billy E, Lynch CJ, Sharp SY, Te Poele R, Fee LO, Foote KM, Green S, Workman P, Jones K (2016) Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9. Medchemcomm 7(8):1580–1586
Saibil H (2013) Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol 14(10):630–642
Sandqvist A, Sistonen L (2004) Nuclear stress granules: the awakening of a sleeping beauty? J Cell Biol 164(1):15–17
Santagata S, Xu YM, Wijeratne EM, Kontnik R, Rooney C, Perley CC, Kwon H, Clardy J, Kesari S, Whitesell L, Lindquist S, Gunatilaka AA (2012) Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chem Biol 7(2):340–349
Santagata S, Mendillo ML, Tang YC, Subramanian A, Perley CC, Roche SP, Wong B, Narayan R, Kwon H, Koeva M, Amon A, Golub TR, Porco JA Jr, Whitesell L, Lindquist S (2013) Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. Science 341(6143):1238303
Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI, Overington JP (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 6(1):19–34
Sawyers CL (2005) Making progress through molecular attacks on cancer. Cold Spring Harb Symp Quant Biol 70:479–482
Scannell JW, Bosley J (2016) When quality beats quantity: decision theory, drug discovery, and the reproducibility crisis. PLoS One 11(2):e0147215
Schenone M, Dančík V, Wagner BK, Clemons PA (2013) Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 9(4):232–240
Schirle M, Jenkins JL (2016) Identifying compound efficacy targets in phenotypic drug discovery. Drug Discov Today 21:82–89
Shi Y, Inoue H, Wu JC, Yamanaka S (2017) Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 16:115–130
Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10:507–519
Thomas N (2010) High-content screening: a decade of evolution. J Biomol Screen 15(1):1–9
Vilaboa N, Boré A, Martin-Saavedra F, Bayford M, Winfield N, Firth-Clark S, Kirton SB, Voellmy R (2017) New inhibitor targeting human transcription factor HSF1: effects on the heat shock response and tumor cell survival. Nucleic Acids Res 45(10):5797–5817
Vydra N, Toma A, Widlak W (2014) Pleiotropic role of HSF1 in neoplastic transformation. Curr Cancer Drug Targets 14(2):144–155
Wagner BK (2016) The resurgence of phenotypic screening in drug discovery and development. Expert Opin Drug Discovery 11(2):121–125
Wagner BK, Schreiber SL (2016) The power of sophisticated phenotypic screening and modern mechanism-of-action methods. Cell Chem Biol 23:3–9
Wassermann AM, Lounkine E, Hoepfner D, Le Goff G, King FJ, Studer C, Peltier JM, Grippo ML, Prindle V, Tao J, Schuffenhauer A, Wallace IM, Chen S, Krastel P, Cobos-Correa A, Parker CN, Davies JW, Glick M (2015) Dark chemical matter as a promising starting point for drug lead discovery. Nat Chem Biol 11(12):958–966
Westerheide SD, Bosman JD, Mbadugha BN, Kawahara TL, Matsumoto G, Kim S, Gu W, Devlin JP, Silverman RB, Morimoto RI (2004) Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem 279(53):56,053–56,060
Westerheide SD, Kawahara TL, Orton K, Morimoto RI (2006) Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 281(14):9616–9622
Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI (2009) Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323(5917):1063–1066
Workman P (2005) Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeutics. Cold Spring Harb Symp Quant Biol 70:499–515
Xu K, Sun X, Erokwu BO, Cernak I, Lamanna JC (2011) A heat-shock protein co-inducer treatment improves behavioral performance in rats exposed to hypoxia. Adv Exp Med Biol 701:313–318
Yoon IS, Au Q, Barber JR, Ng SC, Zhang B (2010) Development of a high-throughput screening assay for cytoprotective agents in rotenone-induced cell death. Anal Biochem 407(2):205–210
Yoon YJ, Kim JA, Shin KD, Shin DS, Han YM, Lee YJ, Lee JS, Kwon BM, Han DC (2011) KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter. J Biol Chem 286(3):1737–1747
Zeng XC, Bhasin S, Wu X, Lee JG, Maffi S, Nichols CJ, Lee KJ, Taylor JP, Greene LE, Eisenberg E (2004) Hsp70 dynamics in vivo: effect of heat shock and protein aggregation. J Cell Sci 117(Pt 21):4991–5000
Zhang D, Zhang B (2016) Selective killing of cancer cells by small molecules targeting heat shock stress response. Biochem Biophys Res Commun 478(4):1509–1514
Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67–73
Zhang B, Gu X, Uppalapati U, Ashwell MA, Leggett DS, Li CJ (2008) High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathways. J Biomol Screen 13(6):538–543
Zhang B, Au Q, Yoon IS, Tremblay MH, Yip G, Zhou Y, Barber JR, Ng SC (2009a) Identification of small-molecule HSF1 amplifiers by high content screening in protection of cells from stress induced injury. Biochem Biophys Res Commun 390(3):925–930
Zhang Y, Au Q, Zhang M, Barber JR, Ng SC, Zhang B (2009b) Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity. Biochem Biophys Res Commun 386(4):729–733
Zhang W, Bai Y, Wang Y, Xiao W (2016) Polypharmacology in drug discovery: a review from systems pharmacology perspective. Curr Pharm Des 22:3171–3181
Zhou Y, Liu G, Chen J, Reddy PS, Yoon IS, Zhang M, Zhang B (2009) Barber, J.R, Ng, S.C. (2009a) Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives: their cytoprotection effect from rotenone toxicity and preliminary DMPK properties. Bioorg Med Chem Lett 19(21):6114–6118
Zhou Y, Vu K, Chen Y, Pham J, Brady T, Liu G, Chen J, Nam J, Murali Mohan Reddy PS, Au Q, Yoon IS, Tremblay MH, Yip G, Cher C, Zhang B, Barber JR, Ng SC (2009b) Chloro-oxime derivatives as novel small molecule chaperone amplifiers. Bioorg Med Chem Lett 19(11):3128–3135
Zhou Y, Wei L, Brady TP, Murali Mohan Redddy PS, Nguyen T, Chen J, Au Q, Yoon IS, Yip G, Zhang B, Barber JR, Ng SC (2009c) Pyrimido [5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers. Bioorg Med Chem Lett 19(15):4303–4307
Acknowledgements
The authors would like to thank all the supports received from everyone at Alpine Therapeutics, Inc. Special acknowledgements are given to Dr. Dorothy Wang for her critical review of the manuscript.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Zhang, D., Zhang, B. (2018). High Content Screening of Small Molecule Modulators Targeting Heat Shock Response Pathway. In: Asea, A., Kaur, P. (eds) Heat Shock Proteins and Stress. Heat Shock Proteins, vol 15. Springer, Cham. https://doi.org/10.1007/978-3-319-90725-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-90725-3_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90724-6
Online ISBN: 978-3-319-90725-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)